Dr. James Conrad Giebink, MD

Dr. Giebink practices at Atlantis Diagnostics in Melbourne, Florida.

Dr. Giebink's NPI, 1689652091, was assigned on January 5, 2006. Dr. Giebink graduated from Perelman School of Medicine - Philadelphia in 1971. Dr. Giebink holds Florida license ME38372.

Dr. Giebink's primary practice is Atlantis Diagnostics, at 1344 S. Apollo Blvd., Melbourne, FL 32901. The practice phone is (321) 777-7888.

Dr. Giebink's primary practice is Atlantis Diagnostics in Melbourne, Florida. Dr. Giebink is also affiliated with Viera Hospital. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Giebink to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giebink practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Giebink's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Giebink is board certified in radiology by the American Board of Radiology. Dmand AI has Dr. Giebink's licenses on file in 8 states: Florida, California, South Dakota, Illinois, Kansas, Kentucky, Wisconsin and Iowa.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation and cancer radiation-upper GI among the conditions Dr. Giebink treats.

CMS data shows 1,398 Medicare services from Dr. Giebink across 10 procedure codes in 2024, for 218 Medicare patients. Medicare paid $225,698 for them. Every service was in an office.

CMS counts 218 Medicare patients who saw Dr. Giebink in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Giebink's median patient age at 75, with 28% women.

In 2024, Dr. Giebink wrote 37 Medicare Part D claims for 11 patients. 81% of them were for generic drugs. CMS names the drug for 25 of them, across 1 drug with 11 or more claims each, at $199 in total drug cost. In 2018, CMS named 58 claims across 2 drugs.

Dr. Giebink accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 152 general payments to Dr. Giebink from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $1,838.

Dmand AI lists 1 award for Dr. Giebink, most recently CMS Stage 1 EHR in 2013.

Dr. Giebink graduated from Perelman School of Medicine - Philadelphia in 1971.

Dr. Giebink is in network with 21 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.